Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies
The dormant phenotype of Mycobacterium tuberculosis that develops during infection poses a major challenge in disease treatment, since these bacilli show tolerance to front-line drugs. An in vitro hypoxia dormancy model was established, which produced phenotypically dormant Mycobacterium smegmatis a...
Main Authors: | Shweta Sharma, Rupesh Chikhale, Nivedita Shinde, A. M. Khan, Vivek Kumar Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1111997/full |
Similar Items
-
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
by: Akanksha Verma, et al.
Published: (2022-12-01) -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
by: Lanfranco Fattorini, et al.
Published: (2013-11-01) -
In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection
by: Peng Cheng, et al.
Published: (2022-06-01) -
Targeting Non-Replicating <i>Mycobacterium tuberculosis</i> and Latent Infection: Alternatives and Perspectives (Mini-Review)
by: Anna Egorova, et al.
Published: (2021-12-01) -
Tuberculosis infection among children under six in contact with smear positive cases: A study in a hyper endemic area of Iran
by: Mahdi Afshari, et al.
Published: (2023-02-01)